Get the Stockscreener App
4.44
0.45%
-0.02
After Hours:
4.45
0.010
+0.23%
Neuraxis Inc stock is traded at $4.44, with a volume of 45,779.
It is down -0.45% in the last 24 hours and up +66.29% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$4.46
Open:
$4.39
24h Volume:
45,779
Relative Volume:
0.07
Market Cap:
$47.30M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-5.5046
EPS:
-0.8066
Net Cash Flow:
-
1W Performance:
-2.20%
1M Performance:
+66.29%
6M Performance:
+64.44%
1Y Performance:
+71.43%
1-Day Range:
$4.39
$4.55
1-Week Range:
$4.34
$4.64
52-Week Range:
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
4.44 | 47.51M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuraxis Inc Stock (NRXS) Latest News
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis - Nasdaq
Top Stock Reports for Meta, Bank of America & Procter & Gamble - Yahoo Finance
Aug PreEarnings: Can NeurAxis Inc stock double in next 5 years2025 Geopolitical Influence & Verified Trade Idea Suggestions - moha.gov.vn
Glenmark Will Innovation PayMarket Sentiment Indicators & Double Or Triple Capital - bollywoodhelpline.com
Neuraxis Inc. (NRXS) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Candlestick Reversal Detected on Universal Cables Limited’s ChartMarket Sentiment Shifts & Small Budget Wealth Tips - bollywoodhelpline.com
Portfolio Recap: Can NeurAxis Inc stock weather global recessionQuarterly Investment Review & Stepwise Trade Execution Plans - moha.gov.vn
NeurAxis (NASDAQ:NRXS) Director Gil Aharon Purchases 286,138 Shares - Defense World
NeurAxis Insider Makes Bold Multi-Million Move in the Market - TipRanks
Neuraxis Insider Bought Shares Worth $1,007,206, According to a Recent SEC Filing - marketscreener.com
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
Neuraxis achieves medical coverage policy milestone for PENFS - MSN
Craig-Hallum Maintains NeurAxis (NRXS) Buy Recommendation - Nasdaq
Aug Volume: Is NeurAxis Inc stock a safe haven assetM&A Rumor & Risk Controlled Daily Plans - moha.gov.vn
NRXS: Craig-Hallum Raises Price Target to $8.00, Maintains Buy R - GuruFocus
NeurAxis Expands VA Network and Secures Significant Coverage - timothysykes.com
Analyst Downgrade: What technical patterns form on Unith Ltd CM30 stock chartsWeekly Trade Analysis & Community Trade Idea Sharing Platform - moha.gov.vn
NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements - StocksToTrade
NeurAxis Secures Major Health Insurance Coverages - timothysykes.com
How analysts rate NeurAxis Inc. stock todayFed Meeting & Free Weekly Watchlist of Top Performers - Улправда
Aug Macro: How NeurAxis Inc. stock reacts to global recession fears2025 Key Lessons & High Conviction Trade Alerts - Улправда
Can NeurAxis Inc. stock double in next 5 years2025 Market Trends & Step-by-Step Trade Execution Guides - Улправда
Will Neuraxis Inc. stock profit from fiscal stimulusWeekly Profit Analysis & Accurate Buy Signal Notifications - Улправда
Why NeurAxis Stock Climbed 15% - StocksToTrade
NeurAxis Stock Surges: Evaluating The Market Impact - timothysykes.com
Surprises Report: How analysts rate NeurAxis Inc. stock todayWeekly Profit Recap & High Conviction Investment Ideas - Улправда
Will Neuraxis Inc. stock outperform foreign stocksWeekly Gains Report & Daily Risk Controlled Trade Plans - DonanımHaber
NeurAxis Inc.’s New Path in VA: What This Means - timothysykes.com
NeurAxis Achieves Medical Coverage Policy Milestone, - GlobeNewswire
Will Neuraxis Inc. stock outperform energy sector in 2025Trade Performance Summary & Step-by-Step Trade Execution Guides - DonanımHaber
How NeurAxis Inc. stock reacts to global recession fearsTrade Volume Summary & Intraday High Probability Setup Alerts - Улправда
Earnings Risk: How higher bond yields impact Neuraxis Inc stockJuly 2025 Update & Capital Efficient Trading Techniques - moha.gov.vn
Breakout Move: Will Neuraxis Inc stock outperform energy sector in 2025Entry Point & Precise Trade Entry Recommendations - moha.gov.vn
NeurAxis, Inc. Earnings Call: Growth Amid Challenges - MSN
Is Neuraxis Inc. stock a defensive play amid uncertaintyJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
Is Neuraxis Inc. stock good for wealth creationQuarterly Profit Review & Low Drawdown Investment Ideas - Newser
Chronic Constipation Market Set to Grow Substantially Through 2034, DelveInsight Projects - openPR.com
How supply shortages influence Neuraxis Inc. stock2025 Support & Resistance & High Yield Stock Recommendations - Newser
Is Neuraxis Inc. stock undervalued after correctionJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Neuraxis secures VA Federal Supply Schedule contract - MSN
What dividend safety rating applies to Neuraxis Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS) - The Globe and Mail
Neuraxis secures veterans affairs federal supply schedule contract, broadening access to more patients with functional abdominal pain - MarketScreener
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain - The Manila Times
NeurAxis Secures Veterans Affairs Federal Supply Schedule - GlobeNewswire
NeurAxis, Inc. (NRXS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
NeurAxis Expands Stock Offering to $6.27 Million - MSN
Neuraxis Inc Stock (NRXS) Financials Data
There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
28.63%
Cap:
|
Volume (24h):